Claritev Corp
Claritev (CTEV) appointed Jennifer Main to its Board and Audit Committee, effective October 15, 2026, while Jason Kap left the Audit Committee. The board expanded from 11 to 12 members, and Main will receive standard compensation and indemnification.
Claritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EXHIBIT 99.1 Claritev Appoints Jennifer Main to its Board of Directors Board gains deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy McLean, VA — October 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV
Claritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning CTEV (Claritev Corp). Coverage has been balanced: 0 bullish, 3 neutral, and 0 bearish.
Recent CTEV coverage spans corporate actions, insider activity and financial news.
In the last 30 days, CTEV insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($414K). The most active reporter was Garis Douglas Michael, EVP&CFO, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Board composition change may slightly affect governance perception.
Board appointment adds experienced healthcare and finance leadership, potentially supporting strategic execution.
Claritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
Board addition adds AI expertise; modest impact on share price.
Board addition may signal strategic focus on AI but no immediate financial impact.
AlphAI scores every news story that mentions CTEV with an AI model for sentiment and relevance, and aggregates insider trades from Claritev Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Claritev (CTEV) appointed Jennifer Main to its Board and Audit Committee, effective October 15, 2026, while Jason Kap left the Audit Committee. The board expanded from 11 to 12 members, and Main will receive standard compensation and indemnification.
1 min readClaritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EXHIBIT 99.1 Claritev Appoints Jennifer Main to its Board of Directors Board gains deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy McLean, VA — October 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV
1 min readClaritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
1 min readClaritev Corporation (NYSE: CTEV) appointed Ben Letham to its Board of Directors, effective September 14, 2026. Letham, a research scientist at Meta (Nasdaq: META), brings expertise in AI and optimization systems. The company aims to leverage his experience to support its AI-driven growth strategy in healthcare technology.
2 min readClaritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Claritev Appoints Ben Letham to its Board of Directors Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy McLean, VA — September 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and
1 min readClaritev (CTEV) reported Q2 revenue of $257.5M, up 6.6%, raising full-year guidance to $1B-$1.02B. Adjusted EBITDA rose 1.1% to $155.8M, but net loss narrowed to $59.2M. Free cash flow doubled to $54.6M, yet unrestricted cash fell to $14.4M. Hedge fund ownership increased, and short interest is 9.03%.
2 min readDalton Travis (Pres., CEO & Executive Chair) purchased 6,450 indirectly-held shares of Claritev Corp (CTEV) at an average of $38.71 ($38.48–$38.81, $0.25M total) across 2 trades over 2026-08-27 to 2026-08-28.
1 min readMisencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares of Claritev Corp (CTEV) at $40.07 ($0.35M total) on 2026-08-14.
1 min readMintz William B. (SVP, Chief Strategy Officer) sold 8,431 shares of Claritev Corp (CTEV) at $34.24 ($0.29M total) on 2026-08-10.
1 min readPiper Sandler raised its price target for Claritev (NYSE:CTEV) to $73 from $61 and kept an Overweight rating. The stock was about $35.39. The firm cited platform and operating infrastructure improvements, a 1.4 million provider network, and expects profitability in fiscal 2026 with EPS forecast of $5.83.
4 min read
